View of Research Progress and Challenges in the Use of TROP2-Targeted Antibody-Drug Conjugates for the Treatment of Triple-Negative Breast Cancer

Return to Issue Details Research Progress and Challenges in the Use of TROP2-Targeted Antibody-Drug Conjugates for the Treatment of Triple-Negative Breast Cancer Download Download PDF